Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,152 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Hepatic Mac2-BP expression depends on liver fibrosis and inflammation due to fat accumulation in patients with metabolic dysfunction-associated steatotic liver disease.
Uojima H, Tsujikawa H, Yamazaki K, Sugiyama M, Take A, Sakaguchi Y, Gotoh K, Satoh T, Hidaka H, Hayashi S, Kusano C, Sakamoto M, Mizokami M. Uojima H, et al. Among authors: hidaka h. Hepatol Res. 2024 Sep 10. doi: 10.1111/hepr.14109. Online ahead of print. Hepatol Res. 2024. PMID: 39257093
Superparamagnetic iron oxide-enhanced magnetic resonance imaging is useful in predicting malignant potential of vascular transformation of hypointense hypovascular nodules on gadoxetic acid-enhanced magnetic resonance imaging.
Tanaka Y, Nakazawa T, Inoue T, Yamane K, Kubota K, Uojima H, Takada J, Okuwaki Y, Hidaka H, Shibuya A, Kokubu S, Matsunaga K, Koizumi W. Tanaka Y, et al. Among authors: hidaka h. Hepatol Res. 2017 Oct;47(11):1118-1126. doi: 10.1111/hepr.12850. Epub 2017 Feb 21. Hepatol Res. 2017. PMID: 27943555
Prospective, randomized, controlled study of the efficacy of transcatheter arterial chemoembolization with miriplatin for hepatocellular carcinoma.
Kubota K, Hidaka H, Nakazawa T, Okuwaki Y, Yamane K, Inoue T, Uojima H, Takada J, Tanaka Y, Shibuya A, Fujii K, Woodhams R, Matsunaga K, Kokubu S, Koizumi W. Kubota K, et al. Among authors: hidaka h. Hepatol Res. 2018 Feb;48(3):E98-E106. doi: 10.1111/hepr.12933. Epub 2017 Jul 30. Hepatol Res. 2018. PMID: 28656607
Late Relapse after a Sustained Virologic Response at 24 Weeks after Treatment with Daclatasvir and Asunaprevir Combination Therapy for Chronic Hepatitis C Virus Genotype 1b Infection with Liver Cirrhosis.
Uojima H, Murakami S, Nakatani S, Hidaka H, Takeuchi A, Tanaka Y, Inoue T, Yamane K, Kubota K, Nakazawa T, Shibuya A, Tanaka Y, Koizumi W. Uojima H, et al. Among authors: hidaka h. Intern Med. 2018 Apr 1;57(7):951-956. doi: 10.2169/internalmedicine.9671-17. Epub 2017 Dec 8. Intern Med. 2018. PMID: 29225269 Free PMC article.
Relationship between response to lusutrombopag and splenic volume.
Uojima H, Arase Y, Itokawa N, Atsukawa M, Satoh T, Miyazaki K, Hidaka H, Sung JH, Kako M, Tsuruya K, Kagawa T, Iwakiri K, Horie R, Koizumi W. Uojima H, et al. Among authors: hidaka h. World J Gastroenterol. 2018 Dec 14;24(46):5271-5279. doi: 10.3748/wjg.v24.i46.5271. World J Gastroenterol. 2018. PMID: 30581275 Free PMC article.
1,152 results